Planta Medica · 2013 · 27 citations · 0 references
MedicineBiochemistryPharmacologyInflammationInnate ImmunityMolecular PharmacologyAnti-inflammatory PharmacologyCytokine BiologyInflammation PharmacologyInflammatory Cell SignalingInflammatory SignalingMacrophage PharmacologyAnti-inflammatory ActivityBioactive Compounds From Marine EchinodermsBioassay-guided FractionationFractionationNf-κb SignalingNitric OxideNitric Oxide ProductionNitric Oxide Synthase Regulation
In this study, we aimed to identify the compounds in <i>Eclipta prostrata</i> responsible for its anti-inflammatory effects using an <i>in vitro</i> bioassay. Three triterpenoids, eclalbasaponin I, eclalbasaponin II, and echinocystic acid, were isolated from an EtOAc fraction of the 70 % EtOH extract of <i>E. prostrata</i> by activity-guided fractionation based on the inhibition of nitric oxide release from lipopolysaccharide-induced RAW 264.7 macrophages. Of these three triterpenoids, echinocystic acid inhibited lipopolysaccharide-induced production of nitric oxide and cytokines such as tumor necrosis factor-<i>α</i> and interleukin-6. Consistent with these observations, echinocystic acid concentration-dependently inhibited lipopolysaccharide-induced inducible nitric oxide synthase expression at the protein level and inducible nitric oxide synthase, tumor necrosis factor-<i>α</i>, and interleukin-6 expression at the mRNA level, and inhibited lipopolysaccharide-induced iNOS promoter binding activity. In addition, echinocystic acid suppressed the lipopolysaccharide-induced transcriptional activity of nuclear factor-<i>κ</i>B by blocking the nuclear translocation of p65.